| |
| |
|
| Insider
Information: |
Kassberg Thomas Richard |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
252,823 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,129,268 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
252,823 |
|
|
| Total
Value |
$11,129,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -202.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Former SVP-Cor.Dev.Com... |
2007-12-28 |
0 |
2006-01-16 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-11 |
252,823 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2024-03-11 |
4 |
S |
$49.93 |
$574,644 |
D/D |
(11,509) |
252,823 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2024-03-01 |
4 |
S |
$53.76 |
$54,351 |
D/D |
(1,011) |
264,332 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2024-03-01 |
4 |
D |
$53.69 |
$14,711 |
D/D |
(274) |
265,343 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,757 |
265,617 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2023-10-23 |
4 |
OE |
$6.86 |
$273,563 |
D/D |
39,878 |
286,738 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2023-10-23 |
4 |
S |
$32.78 |
$1,307,201 |
D/D |
(39,878) |
246,860 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2023-03-01 |
4 |
D |
$45.65 |
$154,936 |
D/D |
(3,394) |
246,860 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2023-03-01 |
4 |
S |
$45.27 |
$89,091 |
D/D |
(1,968) |
250,254 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,663 |
252,222 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2022-03-11 |
4 |
S |
$67.01 |
$688,930 |
D/D |
(10,281) |
227,559 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2022-03-01 |
4 |
S |
$66.62 |
$158,156 |
D/D |
(2,374) |
213,840 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
227,840 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$23,206 |
D/D |
(286) |
216,266 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-09-30 |
4 |
OE |
$0.31 |
$34,018 |
D/D |
109,734 |
216,552 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-05-06 |
4 |
S |
$113.69 |
$41,269 |
D/D |
(363) |
106,818 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
111,614 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-03-01 |
4 |
S |
$138.17 |
$631,713 |
D/D |
(4,572) |
107,181 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-10-14 |
4 |
S |
$87.98 |
$23,051 |
D/D |
(262) |
101,478 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,740 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-05-06 |
4 |
D |
$66.26 |
$16,432 |
D/D |
(248) |
101,675 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-04-19 |
4 |
D |
$58.57 |
$14,525 |
D/D |
(248) |
101,923 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,434 |
104,109 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-03-01 |
4 |
D |
$56.08 |
$115,917 |
D/D |
(2,067) |
102,171 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
91,675 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-06-01 |
4 |
D |
$54.93 |
$19,006 |
D/D |
(346) |
90,241 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
